These outcomes, along with a previous report exhibiting that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like actions in mice,2 support the strategy of concentrating on ACKR3 as a singular technique to modulate the opioid system, which could open up new therapeutic avenues for opioid-related disorders. In response to this https://englandg012ujw1.newsbloger.com/profile